Table 3 Details of patients who developed coronary artery abnormalities
āCase no. | Sex | Onset age (months) | Symptom at 1 month after onset | Maximum size of CA lesion (mm) | CRP at 1 month after onset (mg/dl) | Anticoaglant therapy at 1 year after onset | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
At defervescence | At 1 month after onset | At 1 year after onset | |||||||||||
Day | RCA | LCA | RCA | LCA | RCA | LCA | |||||||
Group A | 1 | F | 4 | conjunctivitis lip erythema | 13 | 1.7 | 2.0 | 3.3 | 2.1 | 2.1 | 1.9 | 4.0 | Yes |
| Ā | 2 | F | 11 | lip erythema | 10 | 2.2 | 1.8 | 4.5 | 4.5 | 3.0 | 2.3 | 2.9 | Yes |
| Ā | 3 | M | 47 | conjunctivitis | 12 | 2.6 | 2.5 | 4.5 | 8.7 | 2.5 | 2.5 | ā¤0.2 | Yes |
| Ā | 4 | M | 17 | lip erythema | 12 | 3.4 | 7.5 | 2.8 | 7.8 | 2.7 | 4.5 | n.d. | No |
Group B | 5 | M | 28 | None | 18 | 3.1 | 3.5 | 2.6 | 3.4 | 2.0 | 2.2 | n.d | Yes |
| Ā | 6 | M | 37 | None | 9 | 2.0 | 2.8 | 2.5 | 3.3 | 2.6 | 2.9 | ā¤0.2 | No |
| Ā | 7 | M | 4 | None | 7 | 2.1 | 1.9 | 4.2 | 4.4 | 2.2 | 2.2 | n.d. | Yes |